Clinical Trial Update: Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluated the pharmacokinetics of an oral arsenic trioxide solution under fasting and fed conditions and compared it to intravenous arsenic trioxi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• intravenous arsenic trioxide (arsenic trioxide)
• oral arsenic trioxide solution (arsenic trioxide)

Snippet

Sponsor: SDK Therapeutics, Inc. | Conditions: Acute Promyelocytic Leukemia (APL) | Phase 1 | Status: COMPLETED